L-DOPA up-regulates glutathione and protects mesencephalic cultures against oxidative stress

Journal of Neurochemistry

Volumn 66, Issue 2, 1996, Pages 501-510

  Han, Shan Kuo ^a   Mytilineou, Catherine ^a   Cohen, Gerald ^a,b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Autooxidation; Cell cultures; Glutathione; L DOPA; Neuroprotection; tert Butylhydroperoxide

Indexed keywords

APOMORPHINE; BUTYL HYDROPEROXIDE; CATECHOL; DOPAMINE; GLUTATHIONE; HYDROQUINONE; LEVODOPA; METHYLDOPA; RESORCINOL; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOOXIDATION; CELL CULTURE; CELL PROTECTION; FETUS; MESENCEPHALON; NEUROBLASTOMA; NEUROPROTECTION; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; STRUCTURE ACTIVITY RELATION;

ANIMALIA; SUS SCROFA;

EID: 0030059868     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66020501.x     Document Type: Article

References (55)

1. Bannai S., Sato H., Ishii T., and Sugita Y. (1989) Induction of cystine transport activity in human fibroblasts by oxygen. J. Biol. Chem. 264, 18480-18484.
2. Basma A. N., Morris E. J., Nicklas W. J., and Geller H. M. ( 1995) L-DOPA cytotoxicity to PC12 cells in culture is via its autoxidation. J. Neurochem. 64, 825-832.
3. Bellomo G., Mirabelli F., Vairetti M., Iosi F., and Malorni W. (1990) Cytoskeleton as a target m menadione-induccd oxidative stress in cultured mammalian cells. I. Biochemical and immunocytochemical features. J. Cell. Physiol. 143, 118-128.
4. Bergmeyer H.-U., Bernt E., and Hess B. (1963) Lactic dehydrogenase, in Methods of Enzymatic Analysis (Bergmeyer H.-U., ed), pp. 736-741. Academic Press, New York.
5. Bottenstein J. E. and Sato G. H. (1979) Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci. USA 16, 514-517.
6. Bridges R. J., Koh J.-Y., Hatalski C. G., and Cotman C. W. (1991) Increased excitotoxic vulnerability of cortical cultures with reduced levels of glutathione. Eur. J. Pharmacol. 192, 199-200.
7. Ceballos I., Lafon M., Javoy-Agid F., Hirsch E., Nicole A., Sinet P. M., and Agid Y. (1990) Superoxide dismutase and Parkinson's disease. Lancet 335, 1035-1036.
8. Cohen G. (1983) Catalase, glutathione peroxidase, superoxide dismutase and cytochrome P-450, in Handbook of Neurochemistiy, Vol. 4, 2nd edit. (Lajtha A., ed), pp. 315-328. Plenum, New York.
9. Cohen G. and Werner P. (1993) Free radicals, oxidative stress, and neurodegeneration, in Neurodegenerative Diseases (Calne D. B., ed), pp. 139-161. W. B. Saunders Co., Philadelphia.
10. Damier P., Hirsch E. C., Zhang P., Agid Y., and Javoy-Agid F. (1993) Glutathione peroxidase, glial cells and Parkinson's disease. Neuroscience 52, 1-6.
11. Di Monte D., Ross D., Bellomo G., Elkow L., and Orrenius S. (1984) Alterations in intracellular thiol homeostasis during the metabolism of menadione by isolated rat hepatocytes. Arch. Biochem. Biophys. 235, 334-342.
12. Di Simplicio D. and Rossi R. (1994) The time-course of mixed disulfide formation between GSH and proteins in rat blood after oxidative stress with tert-butyl hydroperoxide. Biochim. Biophys. Acta 1199, 245-252.
13. Driscoll B. F., Deibler G. E., Law M. J., and Crane A. M (1993) Damage to neurons in culture following medium change: role of glutamine and extracellular generation of glutamate. J. Neurochem. 61, 1795-1800.
14. Dybing E., Nelson S. D., Mitchell J. R., Sasame H. A., and Gillette J. R. (1976) Oxidation of alpha-methyldopa and other catechols by cytochrome P-450-generated superoxide anion: possible mechanism of alpha-methyldopa hepatitis. Mol. Pharmacol. 12, 911-920.
15. Fahn S. and Cohen G. (1992) The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol. 32, 804-812.
16. Graham D. G., Tiffany S. M., Bell W. R., and Gutknecht W. F. (1978) Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine and related compounds towards C1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14, 644-653.
17. Grenader A. and Healy D. P. (1991) Locally formed dopamine stimulates cAMP accumulation in LLC-PK1 cells via a DA1 dopamine receptor. Am. J. Physiol. 260, F906-F912.
18. Hassan H. and Fridovich I. (1977) Regulation of the synthesis of superoxide dismutase in Escherichia coli: induction by methyl viologen. J. Biol. Chem. 252, 7667-7672.
19. Heikkila R. E. and Cohen G. (1973) 6-Hydroxydopamine: evidence for superoxide radical as an oxidative intermediate. Science 181, 456-457.
20. Ito S. (1993) High-performance liquid chromatography (HPLC) analysis of eu- and pheomelanin in melanogenesis control. J. Invest. Dermatol 100 (Suppl. 2), 166S-171S.
21. Jain A., Martensson J., Stole E., Auld P. A. M., and Meister A. (1991) Glutathione deficiency leads to mitochondrial damage in brain. Proc. Natl. Acad. Sci. USA 88, 1913-1917.
22. Li Y., Lafuente A., and Trush M. A. (1994) Characterization of quinone reductase, glutathione and glutathione-S-transferase in human myeloid cell lines: induction by 1,2-dithiole-3-thione and effect on hydroquinone-induced cytotoxicity. Life Sci. 54, 901-906.
23. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol Chem. 193, 265-275.
24. Makar T. K., Nedergaard M., Preuss A., Gelbard A. S., Perumal A. S., and Cooper A. J. L. (1994) Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: evidence that astrocytes play an important role in antioxidative processes in the brain. J. Neurochem. 62, 45-53.
25. 1 increased adenosine 3′-5′-cyclic monophosphate levels in primary cultures of glia. J. Cyclic Nucleotide Res. 4, 15-26.
26. Meister A. (1991) Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol. Ther. 51, 155-194.
27. Meister A. and Anderson M. E. (1983) Glutathione. Annu. Rev. Biochem. 52, 711-760.
28. Mena M. A., Pardo B., Casarejos M. I., Fahn S., and de Yebenes J. G. (1992) Neurotoxicity of levodopa on catecholamine-rich human neuroblastoma cells. Mov. Disord. 5, 62-73.
29. Mena M. A., Pardo B., Paino C. L., and de Yebenes J. G. (1993) Levodopa toxicity in foetal rat midbrain neurones in culture: modulation by ascorbic acid. Neuroreport 4, 438-440.
30. Meredith M. J. and Reed D. J. (1983) Depletion in vitro of mitochondrial glutathione in rat hepatocytes and enhancement of lipid peroxidation by adriamycin and 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU). Biochem. Pharmacol. 32, 1383-1388.
31. Michel P. P. and Hefti F. (1990) Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J. Neurosci. Res. 26, 428-435.
32. Misra H. P. and Fridovich I. (1972) The role of superoxide anion in the autoxidation of epinepbrine and a simple assay for superoxide dismutase. J. Biol. Chem. 247, 3170-3175.
33. Moldeus P., Nodenskjold M., Bolasfoldi G., Eiche A., Haglund U., and Lambert B. (1983) Genetic toxicity of dopamine. Mutat. Res. 124, 9-24.
34. Mossman T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
35. Mytilineou C., Han S.-K., and Cohen G. (1993) Toxic and protective effects of L-DOPA on mesencephalic cell cultures. J. Neurochem. 61, 1470-1478.
36. 2 against menadione-induced cell injury in cultured porcine aorta endothelial cells. Chem. Biol. Interact. 78, 67-75.
37. Olanow W. and Arendash G. W. (1994) Metals and free radicals in neurodegeneration. Curr. Opin. Neural. 7, 548-558.
38. Olney J. W., Zoruraski C. F., Stewart G. R., Price M. T., Wang G., and Labruyere J. (1990) Excitotoxicity of L-DOPA and 6-OH-DOPA: implications for Parkinson's and Huntington's diseases. Exp. Neurol. 108, 269-272.
39. Philbert M. A., Beiswanger C. M., Waters D. K., Reuhl K. R., and Lowndes H. E. (1991) Cellular and regional distribution of reduced glutathione in the nervous system of the rat: histochemical localization by mercury orange and o-phthalaldehyde-induced histofluorescence. Toxicol. Appt. Pharmacal. 107, 215-227
40. Pileblad E., Eriksson P. S., and Hansson E. (1991) The presence of glutathione in primary neuronal and astroglial cultures from rat cerebral cortex and brain stem. J. Neural Transm. 86, 43-49.
41. Raps S. P., Lai J. C. K., Hertz L., and Cooper A. J. L. (1989) Glutathione is present in high concentrations in cultured astrocytes but not in cultured neurons. Brain Res. 493, 398-401.
42. Reed D. J. (1990) Glutathione: toxicological implications. Annu. Rev. Pharmacol. Toxicol. 30, 603-631.
43. Reed D. J. and Fariss M. W. (1984) Glutathione depletion and susceptibility. Pharmacol. Rev. 36 (Suppl.), 25S-33S.
44. Rosenberg P. A. (1988) Catecholamine toxicity in cerebral cortex in dissociated cell culture. J. Neurosci. 8, 2887-2894.
45. Sagara J. I., Miura K., and Bannai S. (1993a) Cystine uptake and glutathione level in fetal brain cells in primary culture and suspension. J. Neurochem. 61, 1667-1671.
46. Sagara J. I., Miura K., and Bannai S. (1993b) Maintenance of neuronal glutathione by glial cells. J. Neurochem. 61, 1672-1676.
47. Saggu H., Cooksey J., Dexter D., Wells F. R., Lees A., Jenner P., and Marsden C. D. (1989) A selective increase in particulate superoxide dismutase activity in parkinsoman substantia nigra. J. Neurochem. 53, 692-697.
48. Schmalenbach C. and Muller H. W. (1993) Astroglial-neuron interactions that promote long-term neuronal survival. J. Chem. Neuroanat. 6, 229-237.
49. Shi M. M., Iwamoto T., and Forman H. J. (1994) τ-Glutamylcysteine synthetase and GSH increase in quinone-induced oxidative stress in BPAEC. Am. J. Physiol. 267, L414-L421.
50. Shivakumar B. R. and Ravindranath V. (1993) Oxidative stress and thiol modification induced by chronic administration of haloperidol. J. Pharmacol. Exp. Ther. 265, 1137-1141.
51. Slivka A., Mytilineou C., and Cohen G. ( 1987) Histochemical evaluation of glutathione in brain. Brain Res. 409, 275-284.
52. Steece-Collier K., Collier T. J., Sladek C. D., and Sladek J. R. Jr. (1990) Chronic levodopa impairs morphological development of grafted embryonic dopamine neurons. Exp. Neurol. 110, 201-208.
53. Werner P. and Cohen G. (1993) Glutathione disulfide (GSSG) as a marker of oxidative injury to brain mitochondria. Ann. NY Acad. Sci. 679, 364-369.
54. Wong G., Elwell J. H., Oberley L. W., and Goeddel D. V. (1989) Manganous superoxide dismutase is essential for cellular resistance to the cytotoxic effects of tumor necrosis factor. Cell 58, 923-931.
55. Woods J. S., Davis H. A., and Baer R. P. (1992) Enhancement of gamma-glutamyl-cysteine synthetase mRNA in rat kidney by methyl mercury. Arch. Biochem. Biophys. 296, 350-353.